Related references
Note: Only part of the references are listed.Synthesis of New C-3 Substituted Kynurenic Acid Derivatives
Balint Lorinczi et al.
MOLECULES (2020)
Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms
Rosaria Greco et al.
CEPHALALGIA (2017)
Late stage iodination of biologically active agents using a one-pot process from aryl amines
Nikki L. Sloan et al.
RSC ADVANCES (2017)
Synthesis of prenylated quinolinecarboxylic acid derivatives and their anti-obesity activities
Haruhisa Kikuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Facile construction of N-alkyl arylaminomaleimide derivatives as intensively emissive aggregation induced emission dyes
Kohei Kizaki et al.
TETRAHEDRON (2015)
Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets
Denes Zadori et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex
Annamaria Fejes-Szabo et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Aggregation induced emission characteristics of maleimide derivatives
Muthusamy Boominathan et al.
RSC ADVANCES (2013)
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease
Denes Zadori et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
F. Fueloep et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The Janus-face kynurenic acid
Eva Rozsa et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus:: Comparative studies of the effects of SZR-72 and kynurenic acid
E. Knyihar-Csillik et al.
NEUROSCIENCE RESEARCH (2008)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils
Gabor Gigler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Role of kynurenines in the central and peripherial nervous systems
H Németh et al.
CURRENT NEUROVASCULAR RESEARCH (2005)
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules
S Manfredini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Can the USP paddle method be used to represent in-vivo hydrodynamics?
A Scholz et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors
A Brik et al.
CHEMISTRY & BIOLOGY (2002)
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity
S Manfredini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Kynurenic acid antagonists and kynurenine pathway inhibitors
TW Stone
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Synthesis and evaluation of quinoline carboxyguanidines as antidiabetic agents
D Edmont et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs
FP Bonina et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
